An in silico modeling approach to understanding the dynamics of sarcoidosis

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Aguda, Baltazar D ^a   Marsh, Clay B ^b   Thacker, Michael ^b   Crouser, Elliott D ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ANTIBODY; ANTIGEN;

ANTIGEN PRESENTING CELL; ARTICLE; CELL INTERACTION; COMPUTER MODEL; EFFECTOR CELL; GRANULOMATOUS INFLAMMATION; IMMUNOCOMPETENT CELL; MACROPHAGE; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MEDICAL LITERATURE; PATHOPHYSIOLOGY; PHENOTYPE; REGULATORY T LYMPHOCYTE; SARCOIDOSIS; TREATMENT OUTCOME; BIOLOGICAL MODEL; CELL COMMUNICATION; COMPUTER SIMULATION; DRUG COMBINATION; DRUG EFFECT; GRANULOMA; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PATHOLOGY; TH1 CELL;

ANIMALIA;

ANTIBODIES; ANTIGENS; CELL COMMUNICATION; COMPUTER SIMULATION; DRUG THERAPY, COMBINATION; GRANULOMA; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; PHENOTYPE; SARCOIDOSIS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79957583554     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019544     Document Type: Article

References (32)

1. Iannuzzi MC, Rybicki BA, Teirstein AS, (2007) Sarcoidosis. N Engl J Med 357: 2153-65.
2. Yates A, Callard R, Stark J, (2004) Combining cytokine signaling with T-bet and GATA-3 regulation in Th1 and Th2 differentiation: a model for cellular decision-making. J Theor Biol 231: 181-96.
3. Mariani L, Lohning M, Radbruch A, Hofer T, (2004) Transcriptional control networks of cell differentiation: insights from helper T lymphocytes. Prog Biophys Mol Biol 86: 45-76.
4. Mendoza L, (2006) A network model for the control of the differentiation process in Th cells. Biosystems 84: 101-14.
5. Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, et al. (2006) The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 203: 359-70.
6. Grunewald J, Eklund A, (2007) Role of CD4+ T cells in sarcoidosis. Proc Am Thorac Soc 15: 461-4.
7. Noor A, Knox KS, (2007) Immunopathogenesis of sarcoidosis. Clin Dermatol 25; 250-8.
8. Zissel G, Prasse A, Muller-Quernheim J, (2010) Immunologic response of sarcoidosis. Semin Respir Crit Care Med 31: 390-403.
9. Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevack EM, et al. (2006) TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 108; 253-61.
10. Aguda BD, Goryachev AB, (2007) From pathways databases to network models of switching behavior. PLoS Comput Biol 3: 1674-8.
11. Antony PA, Restifo NP, (2005) CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. J Immunother 28: 120-8.
12. Nagar M, Jacob-Hirsch J, Vernitsky H, Berkun Y, Ben-Horin S, et al. (2010) TNF activates a NF-kappaB-regulated cellular program in human CD45RA-regulatory T cells that modulates their suppressive function. J Immunol 184: 3570-81.
13. Josefowicz SZ, Rudensky A, (2009) Control of regulatory T cell lineage commitment and maintenance. Immunity 30: 616-25.
14. Arazi A, Sharabi A, Zinger H, Mozes E, Neumann AU, (2009) In vivo dynamical interactions between CD4 Tregs, CD8 Tregs and CD4+CD25- cells in mice. PLoS ONE 4: e8447.
15. Bilate AM, Lafaille JJ, (2010) Can TNF-α boost regulatory T cells? J Clin Invest 120: 4190-2.
16. Liu G, Ma H, Qiu L, Li L, Cao Y, et al. (2011) Phenotypic and functional switch of macrophages induced by regulatory CD4(+)CD25(+) T cells in mice. Immunol Cell Biol 89: 130-42.
17. Wu C, Rauch U, Korpos E, Song J, Loser K, et al. (2009) Sialoadhesin-positive macrophages bind regulatory T cells, negatively controlling their expansion and autoimmune disease progression. J Immunol 182: 6508-16.
18. Idali F, Wahlstrom J, Muller-Suur C, Eklund A, Grunewald J, (2008) Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis. Clin Exp Immunol 152: 127-37.
19. Feinerman O, Jentsch G, Tkach KE, Coward JW, Hathorn MM, et al. (2010) Single-cell quantification of IL-2 response by effector and regulatory T cells reveals critical plasticity in immune response. Mol Systems Biol 6: 437.
20. Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, et al. (2006) Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174: 795-802.
21. Judson MA, Baughman RP, Costabel U, Flavin S, Lo KH, et al. (2008) Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomized trial. Eur Respir J 2008; 31: 1189-96.
22. Dhaille F, Viseux V, Caudron A, Dadban A, Tribout C, et al. (2010) Cutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two cases. Dermatology 220: 234-7.
23. Deïen CI, Monnier A, Claudepierre P, Constantin A, Eschard JP, et al. (2009) Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford) 48: 883-6.
24. Winkler T, Venegas JG, (2007) Complex airway behavior and paradoxical responses to bronchoprovocation. J Appl Physiol 103: 655-63.
25. Alencar AM, Arold SP, Buldyrev SV, Majumdar A, Stamenovic D, et al. (2002) Physiology: Dynamic instabilities in the inflated lung. Nature 417: 809-11.
26. Izbicki G, Chavko R, Banauch GI, Weiden MD, Berger KI, et al. (2007) World Trade Center "sarcoidosis-like" granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest 131: 1414-23.
27. Safirstein BH, Klukowicz A, Miller R, Teirstein A, (2003) Granulomatous pneumonitis following exposure to the World Trade Center collapse. Chest 123: 301-4.
28. Valentonyte R, Hampe J, Huse K, Rosenstiel P, Albrecht M, et al. (2005) Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 37: 357-64.
29. Crouser ED, Lozanski G, Fox CC, Hauswirth DW, Raveendran R, et al. (2010) The CD4+ lymphopenic sarcoidosis phenotype is highly responsive to anti-tumor necrosis factor-{alpha} therapy. Chest 137: 1432-5.
30. Sweiss NJ, Salloum R, Ghandi S, Alegre ML, Sawaqed R, et al. (2010) Significant CD4, CD8, CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations. PLoS One 5: e9088.
31. Correale P, Campoccia G, Tsang KY, Micheli L, Cusi MG, et al. (2001) Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2. Results from a phase 1b clinical trial. Eur J Cancer 37: 892-902.
32. Kobayashi T, Okamoto S, Hisamatsu T, Kamada N, Chinen H, et al. (2008) IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 57: 1682-9.